• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Medical Device Market
Medical Device News
Medical Device Stocks
  • Medical Device Market
  • Medical Device News
  • Medical Device Stocks
medical-device-investing

Assure Holdings Reports Q3 2019 Financial Results

Jocelyn Aspa
Nov. 26, 2019 08:12AM PST
Medical Device Investing

The company has released its Q3 2019 financial results for the quarter ended September 30, 2019, highlighting a 105 percent revenue increase.

Assure Holdings (TSXV:IOM, OTCQB:ARHH) has announced its third quarter financial results for the quarter ended September 30, 2019.

As quoted in the press release:

Previously Disclosed Cash Collections Analysis

As we have previously disclosed, Assure performed a cash collection analysis at the end of 2018 to evaluate if the actual cash collections for its historical technical and professional cases was consistent with the amount of revenue that had been recognized for those cases. This analysis showed that the actual amount of cash collections was lower than the amount of revenue recorded for those cases. An adjustment was made in the fourth quarter of 2018 to record the cumulative effect of this difference. Due to the entire revenue adjustment being recorded in the fourth quarter of 2018, the operating results for the third quarter of 2018 were not restated. Accordingly, we have provided pro forma information in this press release to reflect the adjustment as if it occurred at the beginning of 2018. Further details of the adjustment have been provided in the tables at the end of this press release.

Third Quarter 2019 Financial Highlights vs. Revised Third Quarter 2018

  • Total revenue increased 105% to $8.0 million versus a revised pro forma revenue of $3.9 million.
  • Managed cases increased 95% to a quarterly record of 1,519 versus 777.
  • Earnings from equity method of investment in PNEs decreased 23% to $285,000 compared to a revised pro forma amount of $370,000.
  • Net income attributable to Assure stockholders increased 159% to $3.6 million compared to a revised pro forma net income of $1.4 million.
  • Net income per diluted share increased to $0.09 compared to a revised pro forma amount of $0.03 per diluted share.
  • Adjusted EBITDA increased significantly to $5.1 million versus a revised pro forma adjusted EBITDA of $2.3 million.

Nine Months Ended September 2019 Financial Highlights vs. Revised Same Period 2018

  • Total revenue increased 112% to $22.4 million versus a revised pro forma revenue of $10.6 million.
  • Earnings from equity method of investment in PNEs decreased slightly to $1.2 million compared to a revised pro forma amount of $1.3 million.
  • Net income attributable to Assure stockholders increased 143% to $9.3 million compared to a revised pro forma net income of $3.8 million.
  • Net income per diluted share increased to $0.23 compared to a revised pro forma amount of $0.09 per diluted share.
  • Adjusted EBITDA increased 154% to $13.8 million versus a revised pro forma adjusted EBITDA of $5.4 million.

Click here to read the full press release.

q3-financial-results otc-arhh assure-holdings medical-device-investing tsxv-iom
The Conversation (0)

Go Deeper

AI Powered
Paysign, Inc. Reports First Quarter 2024 Financial Results

Paysign, Inc. Reports First Quarter 2024 Financial Results

Teck Reports Unaudited Third Quarter Results for 2021

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Medical Device Investing Stocks

Cardiex Limited

Cardiex Limited (CDX:AU)
CDX:AU

Cleo Diagnostics

Cleo Diagnostics (COV:AU)
COV:AU
More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES